5 days left: Your last chance to connect, scale, and save at TechCrunch Founder Summit 2026
TechCrunch's headline. Reported by TechCrunch.
What TechCrunch reported
5 days to save up to $100, plus a second pass for free to TechCrunch Founder Summit 2026 in Boston on November 4. Register now.
The publisher's own words, quoted for review. Every outlet carrying the story is listed below with its link.
5 days left: Your last chance to connect, scale, and save at TechCrunch Founder Summit 2026. 5 days to save up to $100, plus a second pass for free to TechCrunch Founder Summit 2026 in Boston on November 4. Register now. Covered by 1 publications. TechCrunch: 5 days left: Your last chance to connect, scale, and save at TechCrunch Founder Summit 2026.
Who is covering it
- TechCrunch United States 5 days left: Your last chance to connect, scale, and save at TechCrunch Founder Summit 2026 5 days to save up to $100, plus a second pass for free to TechCrunch Founder Summit 2026 in Boston on November 4. Register now. 4 h ago · Tier 2
Headlines and excerpts are the publishers' own, shown under quotation for review and linked to the originals.
More from Technology
Nigeria’s 2027 elections won’t pause startup investments, says Antler founder
Nigeria’s 2027 general election will not deter Antler from investing in the country’s startup ecosystem, as the global early-stage venture Excerpt, BusinessDay
Source BusinessDay
ANZ Raises Oil Price Forecast as Market Tightens on Iran War
According to Bloomberg Markets, ANZ Group Holdings Ltd has raised its oil price forecast as the market tightens amid the Iran war. Bloomberg reported that oil-market balances are now more fragile than at the start of the Middle East conflict. ANZ said any flareup after the US midterm elections would push prices higher. Only one source was supplied, so there are no conflicting accounts to compare. Summary from 1 source
Summary from 1 source Bloomberg Markets
Georgia parents' $37m verdict cut to $2m, appeals court raises it to $3m
A couple in Georgia has triumphed in their legal battle, securing a $3 million judgment after an appeals court re-evaluated their son's death case. This decision overturned a previous reduction of a $37 million jury award to just $2 million. Their son, who succumbed to stage-four Burkitt lymphoma, f Excerpt, The Times of India
Source The Times of India